Jason R. Dinges is currently an investment advisor at Morningside Technology Advisory LLC, which he joined in 2011.
Extensive experience providing operational and management oversight to early-stage biotechnology companies.
Director of several biopharmaceutical or biotechnology companies: Kezar Life Sciences (NASDAQ: KZR), Enyo Pharma, CellCentric, Cognito Therapeutics, Inotrem, ApicBio, Pinteon Therapeutics, and Allysta Pharmaceuticals.
He has also facilitated multiple financings for private companies. From 2006 to 2011, Dr. Dinges was an associate attorney at Foley & Lardner LLP, practicing intellectual property law in the firm's Chemical, Biotechnology, and Pharmaceutical practice group.
Ph.D. in genetics from Iowa State University and a J.D., with highest distinction, from the University of Iowa College of Law.
Meredith C. Fisher, PhD
Meredith is a Partner with Partners Innovation Fund focusing on early stage investments and company creation.
Previously, she was in the private/family office at Bracebridge Capital serving as Director of Private Investments where she led investments in early stage life science companies.
Prior to that role she led business development for Ginkgo BioWorks- an MIT spin out- and was Senior Director of Technology and Business Development of Enlight Biosciences- a venture creation company founded by PureTech Ventures.
She spent several years working as a scientist in drug discovery and assay development for Idenix Pharmaceuticals and Anadys Pharmaceuticals.
Undergraduate degree from Mount Holyoke College
MBA from the MIT Sloan School of Management
PhD from Harvard University.
Co-founder of Harvard Graduate Women in Science and Engineering (HGWISE).
Meredith is an independent board member at Metera and she represents PIF on the boards of Nocion, ZielBio and Mediar Therapeutics, and as a board observer at Lyndra and Alizé Pharma. She is the 2019-2020 co-chair of WEST (Women in the Enterprise of Science and Technology) and serves as an advisor to Takeda HATCH.